Risks and limits of Triglyceride Genetik

Triglyceride genetics is highly polygenic: hundreds of variants (e.g., in APOA5, LPL, GCKR) each contribute small effects. Direct-to-consumer tests like MyBody-X may analyze a few SNPs, but predictive power is low. Risks include overinterpretation—users may view results as deterministic, ignoring that lifestyle (diet, exercise) dominates triglyceride levels. Limits: these tests lack clinical validation for actionable guidance; a standard lipid panel is far more informative. The provided context documents contain no direct evidence on triglyceride genetics, so claims from DTC tests should be viewed skeptically. Safety note: elevated triglycerides require medical evaluation, not just genetic data.